Enhanced bimatoprost ophthalmic solution
US8933120B2 · kind B2 · utility
13Cited by
32References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2013 |
| Grant date | Jan 13, 2015 |
| Priority date | — |
| Expiry date | Dec 9, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.